SCHEMBL28157364

SCHEMBL28157364

CC(C)N(C)S(=O)(=O)c1ccc(NC(=O)c2ccccc2F)s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.45
▸ MAPT P10636 2/20 0.45
▸ POLB P06746 2/20 0.45
▸ KMT2A Q03164 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ SMN1; SMN2 Q16637 5/20 0.43
▸ GAA P10253 1/20 0.41
▸ NPC1 O15118 4/20 0.41
▸ RAB9A P51151 4/20 0.41
▸ TP53 P04637 2/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ NFKB2 Q00653 1/20 0.41
▸ RELA Q04206 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ PKM P14618 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ KAT6A Q92794 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28156782 0.84 LMNA (0.42) LMNAMAPTPOLBKMT2AMEN1
SCHEMBL28846257 0.84 MEN1 (0.47) LMNAPOLBKMT2AMEN1TDP1
SCHEMBL28157321 0.83 TP53 (0.44) LMNAMAPTPOLBKMT2AMEN1
SCHEMBL28156717 0.82 MEN1 (0.50) LMNAMAPTPOLBKMT2AMEN1
SCHEMBL28156802 0.82 HDAC4 (0.54) LMNAMAPTPOLBKMT2AMEN1
SCHEMBL28156810 0.81 MAPT (0.42) LMNAMAPTPOLBKMT2AMEN1
SCHEMBL28157366 0.80 MAPT (0.41) LMNAMAPTPOLBKMT2AMEN1
SCHEMBL28157305 0.80 MEN1 (0.48) LMNAMAPTPOLBKMT2AMEN1
SCHEMBL16246361 0.80 CFTR (0.48) LMNAMAPTPOLBKMT2AMEN1
SCHEMBL28846370 0.79 GSTO1 (0.42) LMNAMAPTPOLBKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105531268-B Noval chemical compound and its pharmaceutical composition for treating cystic fibrosis 加拉佩格斯股份有限公司 2017-09-12 — — CN disclosed
Send feedback